Aviva Clinical Trial Group In.

Burlington, Ontario L7R 1E2

0 studies enrolling now · 1 studies all time

What they study most

Cardiovascular Disease, High Cardiovascular Risk, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed